Ameritas Investment Partners’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-986
Closed -$5.3K 3349
2025
Q1
$5.3K Hold
986
﹤0.01% 2959
2024
Q4
$7.35K Hold
986
﹤0.01% 2978
2024
Q3
$8.91K Hold
986
﹤0.01% 2953
2024
Q2
$10.5K Buy
+986
New +$10.5K ﹤0.01% 2909
2021
Q2
Sell
-803
Closed -$7K 3230
2021
Q1
$7K Hold
803
﹤0.01% 2955
2020
Q4
$5K Hold
803
﹤0.01% 2983
2020
Q3
$5K Hold
803
﹤0.01% 2987
2020
Q2
$6K Buy
+803
New +$5.87K ﹤0.01% 2927

Other funds holding ULBI

Ameritas Investment Partners's ULBI Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Ultralife (ULBI) in Q2 2025, closing a stake of 986 shares — an estimated $5.3K sold.

Ameritas Investment Partners first reported a position in ULBI in Q2 2020 and held it in 8 quarters. The position peaked at $10.5K in Q2 2024. 63 funds tracked by Wall St. Rank hold ULBI as of Q2 2025.

  • Ameritas Investment Partners reported no remaining Ultralife position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 986 Ultralife shares in Q2 2025, an estimated $5.3K.
  • Ameritas Investment Partners first reported a position in Ultralife in Q2 2020 and held it in 8 quarters.
  • Ameritas Investment Partners's Ultralife position peaked at $10.5K in Q2 2024.
  • 63 funds tracked by Wall St. Rank held Ultralife as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.